WHO ICTRP trial
Randomized Crossover Trial on the Effect of Henagliflozin on Heart Stress in…
ChiCTR2500108869 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500108869 |
|---|---|
| Public title | Randomized Crossover Trial on the Effect of Henagliflozin on Heart Stress in Patients with Stage B Heart Failure |
| Scientific title | Randomized Crossover Trial on the Effect of Henagliflozin on Heart Stress in Patients with Stage B Heart Failure |
| Primary sponsor | Guangdong Provincial Yingde People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 3 |
| Countries | China |
| Conditions | Pre-heart failrue |
| Interventions | Henagliflozin group:Participants are randomly assigned into Henagliflozin group (10mg/qd) for 24 weeks;Control group:Participants are randomly assigned into control group for 24 weeks |
| Registration date | Sep 8, 2025 |
| Target size | Henagliflozin group:19;Control group:19 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: